Prevention of Cardiovascular Complications in Diabetic Patients With Vitamin E Treatment
Status:
Terminated
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether Vitamin E treatment to Diabetic patients,
who carry the Haptoglobin 2-2 Phenotype, prevents cardiovascular complications such as acute
MI and Stroke.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Technion, Israel Institute of Technology
Collaborators:
Clalit Health Services Kennedy-Leigh charitable trust The Kennedy Leigh Charitable Trust
Treatments:
alpha-Tocopherol Tocopherols Tocotrienols Vitamin E Vitamins